The Medicines, Poisons and Therapeutic Goods Act 2022 and the Medicines, Poisons and Therapeutic Goods Regulation 2026 will commence on 5 November 2026.
Visit the Medicines, Poisons and Therapeutic Goods legislation page to learn what this means for you.
Subscribe to Pharmaceutical Services news and updates and receive updates to your email.
An opioid pharmacotherapy substitution program for patients with opioid dependence. The NSW Opioid Treatment Program (OTP) seeks to reduce the social, economic and health harm associated with opioid use.
Prescriptions for Schedule 8 psychostimulant medicines must include the NSW Health approval number issued to the prescriber.
SafeScript NSW provides pharmacists with real-time information about high risk medicines prescribed to a patient. It supports clinical decision making and patient safety.
Prescriptions for Schedule 8 compounded medicines must include the NSW Health approval number issued to the prescriber.
The loss or theft of a S8 or S4D medicine and forged prescriptions must be reported to NSW Health. You must also report loss or damage to drug registers.
Guides to legislative requirements for handling medicines, including the supply of S8 and S4D medicines.
